Follow
Richard E. Gilbert
Richard E. Gilbert
University of Melbourne, St. Michael's Hospital, Austin, Guy's
Verified email at utoronto.ca
Title
Cited by
Cited by
Year
The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury?
RE Gilbert, ME Cooper
Kidney international 56 (5), 1627-1637, 1999
8641999
Hypertension Canada’s 2018 guidelines for diagnosis, risk assessment, prevention, and treatment of hypertension in adults and children
KA Nerenberg, KB Zarnke, AA Leung, K Dasgupta, S Butalia, K McBrien, ...
Canadian Journal of Cardiology 34 (5), 506-525, 2018
6952018
Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes.
ME Cooper, D Vranes, S Youssef, SA Stacker, AJ Cox, B Rizkalla, ...
Diabetes 48 (11), 2229-2239, 1999
6751999
Hypertension Canada's 2016 Canadian hypertension education program guidelines for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of …
AA Leung, K Nerenberg, SS Daskalopoulou, K McBrien, KB Zarnke, ...
Canadian Journal of Cardiology 32 (5), 569-588, 2016
5372016
Independent and additive impact of blood pressure control and angiotensin II receptor blockade on renal outcomes in the irbesartan diabetic nephropathy trial: clinical …
MA Pohl, S Blumenthal, DJ Cordonnier, F De Alvaro, G DeFerrari, ...
Journal of the American Society of Nephrology 16 (10), 3027-3037, 2005
5002005
The 2015 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension
SS Daskalopoulou, DM Rabi, KB Zarnke, K Dasgupta, K Nerenberg, ...
Canadian Journal of Cardiology 31 (5), 549-568, 2015
4872015
Effect of empagliflozin on left ventricular mass in patients with type 2 diabetes mellitus and coronary artery disease: the EMPA-HEART CardioLink-6 randomized clinical trial
S Verma, CD Mazer, AT Yan, T Mason, V Garg, H Teoh, F Zuo, A Quan, ...
Circulation 140 (21), 1693-1702, 2019
4822019
Hypertension Canada’s 2020 comprehensive guidelines for the prevention, diagnosis, risk assessment, and treatment of hypertension in adults and children
DM Rabi, KA McBrien, R Sapir-Pichhadze, M Nakhla, SB Ahmed, ...
Canadian Journal of Cardiology 36 (5), 596-624, 2020
4672020
Hypertension Canada's 2017 guidelines for diagnosis, risk assessment, prevention, and treatment of hypertension in adults
AA Leung, SS Daskalopoulou, K Dasgupta, K McBrien, S Butalia, ...
Canadian Journal of Cardiology 33 (5), 557-576, 2017
4182017
The 2014 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension
K Dasgupta, RR Quinn, KB Zarnke, DM Rabi, P Ravani, ...
Canadian Journal of Cardiology 30 (5), 485-501, 2014
3742014
Expression of transforming growth factor-beta1 and type IV collagen in the renal tubulointerstitium in experimental diabetes: effects of ACE inhibition.
RE Gilbert, A Cox, LL Wu, TJ Allen, UL Hulthen, G Jerums, ME Cooper
Diabetes 47 (3), 414-422, 1998
3611998
Proteinuria and the expression of the podocyte slit diaphragm protein, nephrin, in diabetic nephropathy: effects of angiotensin converting enzyme inhibition
R Langham, D Kelly, A Cox, N Thomson, H Holthöfer, P Zaoui, N Pinel, ...
Diabetologia 45, 1572-1576, 2002
3312002
Heart failure in diabetes: effects of anti-hyperglycaemic drug therapy
RE Gilbert, H Krum
The Lancet 385 (9982), 2107-2117, 2015
3282015
The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2–therapy
DG Hackam, NA Khan, BR Hemmelgarn, SW Rabkin, RM Touyz, ...
Canadian Journal of Cardiology 26 (5), 249-258, 2010
3132010
Direct actions of urotensin II on the heart: implications for cardiac fibrosis and hypertrophy
A Tzanidis, RD Hannan, WG Thomas, D Onan, DJ Autelitano, F See, ...
Circulation research 93 (3), 246-253, 2003
3132003
The 2013 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension
DG Hackam, RR Quinn, P Ravani, DM Rabi, K Dasgupta, ...
Canadian Journal of Cardiology 29 (5), 528-542, 2013
2992013
Are β-blockers as efficacious in patients with diabetes mellitus as in patients without diabetes mellitus who have chronic heart failure? A meta-analysis of large-scale …
SJ Haas, T Vos, RE Gilbert, H Krum
American heart journal 146 (5), 848-853, 2003
2932003
Proximal tubulopathy: prime mover and key therapeutic target in diabetic kidney disease
RE Gilbert
Diabetes 66 (4), 791-800, 2017
2802017
The (Pro)Renin Receptor: Site-Specific and Functional Linkage to the Vacuolar H+-ATPase in the Kidney
A Advani, DJ Kelly, AJ Cox, KE White, SL Advani, K Thai, KA Connelly, ...
Hypertension 54 (2), 261-269, 2009
2802009
Transforming growth factor β1 and renal injury following subtotal nephrectomy in the rat: role of the renin-angiotensin system
LL Wu, A Cox, CJ Roe, M Dziadek, ME Cooper, RE Gilbert
Kidney international 51 (5), 1553-1567, 1997
2801997
The system can't perform the operation now. Try again later.
Articles 1–20